← FDA Drug Approvals (Drugs@FDA)

ANGIOMAX RTU

NDA · New Drug Application · Sponsor: MAIA PHARMS INC · Approved 2019-07-25

Drug application

FDA Application #

NDA211215

Application type

New Drug Application

Brand name

ANGIOMAX RTU

Generic name

BIVALIRUDIN

Active ingredients

BIVALIRUDIN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MAIA PHARMS INC

Manufacturer

MAIA Pharmaceuticals, Inc.

First approval

2019-07-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown